Related Experiment Video
Updated: Mar 12, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Educational video modules for alcohol use disorder: A scalable tool to bridge the treatment gap in hepatology
Zi-Xiang Jin1, Nian-Zhe Sun2,3
1The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China.
Abstract:
The prospective cohort study by Twohig et al evaluates the efficacy of a novel educational video module (EVM) in promoting treatment engagement and reducing alcohol use among hospitalized patients with alcohol-associated liver disease (ALD). Analyzing 42 patients, the study demonstrates that exposure to the EVM significantly increased rates of both pharmacologic (50% vs 22%) and psychosocial (73.8% vs 44%) treatment within 30 days of discharge, while markedly reducing the return to alcohol use (7.9% vs 35.6%) compared to a retrospective control cohort. These findings underscore the potential of a standardized, scalable educational intervention to bridge critical knowledge gaps in alcohol use disorder (AUD) management. While the study highlights the EVM as a powerful tool for patient empowerment and system-level quality improvement, its single-center design and limited sample size necessitate further validation through multicenter randomized trials. This article contextualizes these promising results within the broader challenge of AUD treatment, emphasizing the urgent need to integrate innovative, patient-centered education into standard clinical pathways to alleviate the growing burden of ALD.
More Related Videos
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
10:42Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
CNS Depressants: Alcohol and Nicotine
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment